Frontlight ResearchEarly access
Trial site
Lundquist Inst BioMed at Harbor
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Diabetic eye disease1 trial
- Multiple sclerosis1 trial
- Sarcoma1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026